Search

You searched for "misdiagnosis"

1200 results found

The last three patients: general medicine (Patient Two)

5 June 2023 | | EYE - General
For the second reflection in this series (see Patient One here), Professor Jonathan Rees recounts his experiences of the last patient he saw as a medical registrar, telling the tragic story of a young man’s death and the risks that...

The work of RNIB and ECLOs

4 December 2023 | EYE - General
With more than 2,000,000 people in the UK living with some degree of sight loss and over 300,000 registered as blind or partially sighted, it is important for anyone living with sight loss to know they’re not alone. At what...

The College of Optometrists launches its manifesto for eyecare in Scotland: building on success

9 March 2026 | optometry, allied professions, services
As Scotland marks 20 years since it became the only UK nation to introduce free NHS-funded eye examinations for people of all ages in 2006, The College of Optometrists is calling on the next Scottish Government to continue leading the...

What can artificial intelligence do to improve sustainability in the delivery of ophthalmic care?

1 December 2025 | | sustainability, artificial intelligence, technology
The 2025 NHS 10-year plan, titled ‘Fit for the Future’, emphasises a significant shift from analogue to digital, with a strong focus on integrating AI and other technologies to transform healthcare. The plan aims to make the NHS the "most...

Ocular toxicity secondary to deferoxamine

12 June 2026 | | EYE - Pathology, EYE - Imaging, EYE - Vitreo-Retinal
Patients with myelodysplastic syndromes can develop transfusion-related iron overload as they become dependent on recurrent blood transfusions [1]. Iron chelation therapy is indicated for the treatment of iron overload and one established example of this is deferoxamine. However, deferoxamine ocular...

MOSUK Annual Meeting 2026

25 February 2026
Medical Ophthalmological Society's 27th Annual Meeting

Innovation update: key advances in eyecare transformation in the last year

1 December 2021 | | EYE - Vitreo-Retinal, EYE - Glaucoma, EYE - General
Vishal Shah and his co-authors reflect on examples of innovation in eyecare delivery published in the last year and the implications for the future of eyecare services. The “new normal” is an overused phrase to describe extraordinary measures that have...

Advanced Glaucoma Surgery Course in Africa through the Juba-Bournemouth VISION 2020 LINK

1 October 2019 | | EYE - Glaucoma, EYE - General
In order to enhance specialist skills, particularly for South Sudan, the Juba-Bournemouth VISION 2020 LINK has been offering week-long intensive ophthalmic specialist training for the last three years, in collaboration with the University of Nairobi, the College of Ophthalmology of...

Retinoblastoma – the challenges of a rare cancer and the role of international partnerships

4 October 2023 | | EYE - Paediatrics, EYE - Strabismus
Introduction: the global challenge The global burden of retinoblastoma (Rb) is one in 15,000-18,000 live births, which equates to 8000 new cases worldwide each year. The global disparities in Rb outcome represent a paradigm of health inequality worldwide [1]. In...

My Top Five: Key insights from recent research into uveitis in adults

4 December 2025 | | EYE - Vitreo-Retinal
Uveitis, characterised by inflammation of the uvea – the eye’s middle layer comprising the iris, ciliary body, and choroid – remains a leading cause of visual impairment worldwide [1]. It primarily affects adults aged 20–50 years. Untreated uveitis may cause...

Demodex blepharitis: A transatlantic comparison of treatments available in the UK and US

1 April 2026 | | EYE - Cornea, EYE - Oculoplastic
Demodex blepharitis is widely recognised among eyecare professionals as an important cause of chronic lid margin inflammation, dry eye and ocular surface diseases. The characteristic feature for diagnosis is the presence of waxy deposit at the lash bases on slit...

Discussing treatment modalities for bilateral wet AMD

1 December 2014 | | EYE - Vitreo-Retinal
A 65-year-old lady with bilateral wet AMD and vision of 6/24 comes with an internet search about current therapies. How do you explain the various treatment modalities available? There are two NICE approved treatments for wet age-related macular degeneration (AMD)....